AMR is one of the most pressing scientific and societal concerns of the day. It has been estimated that by 2050, drug and multi drug resistant infections will account for more deaths than cancer and diabetes combined (approx. 10 million deaths per annum by 2050 – O’Neill Report). Addressing AMR requires a coordinated scientific approach which cuts across traditional disciplines with gains in areas such as new medicines, improved diagnostic tests, materials science, prescribing practice, vaccine development and behaviour change all likely to drive progress in this area. The Strathclyde based CDT aims to bring together the research of a team of academics with the goal of investigating new classes of antimicrobial compounds and developing new sensing and imaging technologies. An important aspect of addressing AMR is training future researchers to carry out interdisciplinary research and this is a key aim of the programme.
The CDT is offering three PhD studentships for October 2019 entry. The candidates will benefit from a cohort experience, the combined experience of four primary academic supervisors and the input of an advisory board composed of senior academics, clinicians and the medical device industry. The programme is also supported by National Physical Laboratory (NPL) who will provide access to specialist research facilities and is endorsed by local companies interested in topics such as medical device development and reducing implant associated infection rates.
The highly interdisciplinary nature of the projects should encourage applications from candidates with diverse backgrounds, including but not exclusively: engineering disciplines (electrical, mechanical, biomedical, chemical etc.) chemistry, physics and biological sciences (e.g. microbiology, molecular biology and biochemistry).
This project which is one of three currently available is concerned with the development of new sensing approaches for electrochemical detection of clinically important drug resistant organisms in combination with real time growth imaging and image processing technologies. There is a strong need for new diagnostic technologies in order to enhance antibiotic stewardship and reduce AMR development. The project will make a significant contribution to this area.
If you have any enquiries, particularly around suitability of previous experience please feel free to contact individual members of the supervisory team:
Dr Damion Corrigan – Biomedical Engineering [[email protected]
Dr Paul Murray – Electronic and Electrical Engineering [[email protected]
Dr Katherine Duncan – Strathclyde Institute of Pharmacy and Biomedical Science [[email protected]
These studentships are available for 3.5 years, include a bursary (£15,009 in the first year) are available to UK and EU students and are due to start on the 1st of October 2019. The University of Strathclyde is a leading technology focused University with a strong track record in the development of medical technologies.
To apply, please send your CV and a 1-page motivational statement to one of the academics listed above. Please include the reference: studentship 3 in your email.
No closing date but early applications are encouraged.